Moreover, DNA methylation and mutations of CFTR have been identified in non-small cell lung cancer (NSCLC), which is a common lung malignancy characterized by poor long-term survival that is mainly due to metastasis and tumour relapse [100, 101]. This evidence concerns the gene CFTR and non-small cell lung carcinoma.